Navigation

PRESS RELEASES

Search all of our press releases here.

Search
Generic filters

Try these: Jeff GalvinC. David PauzaHIVFDAAmerican Gene Technologies

AGT’s CEO to Present at the 19th BIO CEO & Investor Conference

By AGT | Feb 3, 2017
Filed Under:

Rockville, MD American Gene Technologies (AGT), a gene technology company with a broad, robust lentiviral delivery platform, announced today that the CEO, Jeff Galvin is presenting at the upcoming BIO CEO & Investor conference. The Conference is being held on February 13 -14, at the Waldorf Astoria New York, New York.  The presentation is schedule for Monday February 13, 2017… [Read More]

AGT’s CEO to Present at NobleCon13

By AGT | Jan 27, 2017
Filed Under:

View: 1.27.16 Press Release – NobleCon13 View: Noble Conference – Investor Presentation View: Webcast

Internationally Recognized Molecular Researcher Joins American Gene Technologies as Collaborator

By AGT | Oct 4, 2016
Filed Under:

ROCKVILLE, MARYLAND (October 4, 2016) – American Gene Technologies International, Inc. (AGT) today announced the appointment of Dr. John J. Rossi, PhD as a collaborator on gene therapy research. Dr. Rossi is a leader in the field of molecular biology and a pioneer in the development of RNA-based therapies for human disease.   “For more than three decades, John J…. [Read More]

Merv Turner to Chair American Gene Technologies’ Scientific Advisory Board

By AGT | Jun 7, 2016
Filed Under:

RENOWNED PHARMACEUTICAL STRATEGIST, MERV TURNER SEES GREAT PROMISE IN AGT’S EMERGING GENE THERAPY AND JOINS MANAGEMENT TO HELP GUIDE PRODUCTS TO COMMERCIALIZATION ROCKVILLE, MARYLAND (June 7, 2016) – American Gene Technologies International, Inc. (AGT) today announced the appointment of Dr. Mervyn Turner as chairman of the company’s scientific advisory board. Turner has more than 30 years of experience in the… [Read More]

Leading Healthcare Innovator Joins Board of Directors of American Gene Technologies

By AGT | May 24, 2016
Filed Under:

ADDITION OF JONATHAN OTTERSTATTER SIGNALS ADDITIONAL MOMENTUM FOR GENE THERAPY PIONEERS ROCKVILLE, MARYLAND (May 24, 2016) – American Gene Technologies International, Inc. (AGT) today announced the appointment of Jonathan (Jon) Otterstatter to its board of directors. Otterstatter is co-founder, president and CEO of Preventice, Inc., and is a proven leader in the development of technological innovations that lead to broad-based… [Read More]

AGT Announces Collaboration with Internationally Recognized Leader in Medical Genetics

By AGT | May 13, 2016
Filed Under:

JERRY VOCKLEY, MD, PHD COLLABORATES WITH AGT ON PHENYLKETONURIA (PKU) ROCKVILLE, Maryland. (May 13, 2016) – American Gene Technologies International, Inc. (AGT) today announced its collaboration with Jerry Vockley, MD, PhD, chief of the Division of Medical Genetics at Children’s Hospital of Pittsburgh of the University of Pittsburgh Medical Center and Cleveland Family Professor of Pediatric Research at the University of Pittsburgh… [Read More]

Subscribe to Press Release and News Updates

Subscribe to our press release and published article updates to be notified when we release new content!

Follow AGT on Social Media